Has PBAC mapped a new way to do deals?
By Megan Brodie 12 months ago | In Comment, Politics, Reimbursement- 12 months ago
20 October 2025 PBAC’s decision to recommend BMS’s PD-1 checkpoint inhibitor for broad use in cancer…
This is subscriber-only content. Please login to continue reading.